MolPros - Translational Cancer Research


Molecular Prediction of Prostate Cancer Risk and Aggressiveness (MolPros) is an inter-disciplinary translational cancer research alliance bringing together experts from Denmark, Germany, China and USA.

The research alliance has been established to develop new molecular tools to:


  • identify men with high risk of prostate cancer
  • to distinguish aggressive from non-aggressive prostate cancer


MolPros was a 4-year project (2011-2014; extended to July 2015) supported by a grant (~2 mil. Euros, 14.5 mil. DKK) from the Danish Council for Strategic Research and co-financed (~1 mil. Euros, 7 mil. DKK) by the involved partners.

The genetic risk test developed in MolPros is used in two studies ProCaRis (2013-2014) and ProCaRis II (2016-2018).

Prof. Torben F. Ørntoft, Dept. of Molecular Medicine, Aarhus University Hospital, Denmark

"Prostate cancer is a fast growing health and economical problem in Denmark with an increase of 7.9% of new cases per year for the last 10 years.
However, we need to develop much more effective methods of identifying whether it's an aggressive or a non-aggressive form of prostate cancer, so we can provide the right treatments fast and accurately.
Treatment regimens that increase the number of cured patients, while decreasing the overall spending by preventing overtreatment."